12 0 2 0 2 B-lower_bound
to 3 5 3 5 O
70 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age

Currently 0 9 22 31 O
receiving 10 19 32 41 O
IV 20 22 42 44 B-treatment
immunomodulating 23 39 45 61 I-treatment
agents 40 46 62 68 I-treatment

Currently 0 9 69 78 O
receiving 10 19 79 88 O
a 20 21 89 90 O
therapy 22 29 91 98 B-treatment
not 30 33 99 102 O
permitted 34 43 103 112 O
during 44 50 113 119 O
the 51 54 120 123 O
study 55 60 124 129 O

Documented 0 10 130 140 O
severe 11 17 141 147 O
hemophilia 18 28 148 158 B-chronic_disease
B 29 30 159 160 I-chronic_disease
( 31 32 161 162 O
FIX 32 35 162 165 B-clinical_variable
activity 36 44 166 174 I-clinical_variable
of 45 47 175 177 O
≤ 48 49 178 179 O
2 50 51 180 181 B-upper_bound
% 51 52 181 182 I-upper_bound
) 52 53 182 183 O
, 53 54 183 184 O
or 55 57 185 187 O
confirmed 58 67 188 197 O
at 68 70 198 200 O
screening 71 80 201 210 O
by 81 83 211 213 O
the 84 87 214 217 O
central 88 95 218 225 O
laboratory 96 106 226 236 O

Human 0 5 237 242 B-chronic_disease
immunodeficiency 6 22 243 259 I-chronic_disease
virus 23 28 260 265 I-chronic_disease
positive 29 37 266 274 O
with 38 42 275 279 O
a 43 44 280 281 O
CD4 45 48 282 285 B-clinical_variable
count 49 54 286 291 I-clinical_variable
< 55 56 292 293 O
200 57 60 294 297 B-upper_bound
/ 60 61 297 298 I-upper_bound
mm3 61 64 298 301 I-upper_bound

Intravenous 0 11 302 313 O
use 12 15 314 317 O
of 16 18 318 320 O
rIX 19 22 321 324 B-treatment
- 22 23 324 325 I-treatment
FP 23 25 325 327 I-treatment
within 26 32 328 334 O
14 33 35 335 337 B-upper_bound
days 36 40 338 342 I-upper_bound
of 41 43 343 345 O
subcutaneous 44 56 346 358 O
administration 57 71 359 373 O
of 72 74 374 376 O
rIX 75 78 377 380 O
- 78 79 380 381 O
FP 79 81 381 383 O

Known 0 5 384 389 O
congenital 6 16 390 400 B-chronic_disease
or 17 19 401 403 O
acquired 20 28 404 412 B-chronic_disease
coagulation 29 40 413 424 I-chronic_disease
disorder 41 49 425 433 I-chronic_disease

Known 0 5 434 439 O
congenital 6 16 440 450 O
or 17 19 451 453 O
acquired 20 28 454 462 B-chronic_disease
coagulation 29 40 463 474 I-chronic_disease
disorder 41 49 475 483 I-chronic_disease
other 50 55 484 489 O
than 56 60 490 494 O
congenital 61 71 495 505 B-chronic_disease
FIX 72 75 506 509 I-chronic_disease
deficiency 76 86 510 520 I-chronic_disease

Known 0 5 521 526 O
hypersensitivity 6 22 527 543 O
( 23 24 544 545 O
ie 24 26 545 547 O
, 26 27 547 548 O
allergic 28 36 549 557 O
reaction 37 45 558 566 O
or 46 48 567 569 O
anaphylaxis 49 60 570 581 O
) 60 61 581 582 O
to 62 64 583 585 O
any 65 68 586 589 O
FIX 69 72 590 593 B-allergy_name
product 73 80 594 601 I-allergy_name
or 81 83 602 604 O
hamster 84 91 605 612 B-allergy_name
protein 92 99 613 620 I-allergy_name

Known 0 5 621 626 O
kidney 6 12 627 633 B-chronic_disease
or 13 15 634 636 O
liver 16 21 637 642 B-chronic_disease
dysfunction 22 33 643 654 I-chronic_disease
or 34 36 655 657 O
any 37 40 658 661 O
condition 41 50 662 671 O
which 51 56 672 677 O
, 56 57 677 678 O
in 58 60 679 681 O
the 61 64 682 685 O
investigator 65 77 686 698 O
's 77 79 698 700 O
opinion 80 87 701 708 O
, 87 88 708 709 O
place 89 94 710 715 O
the 95 98 716 719 O
patient 99 106 720 727 O
at 107 109 728 730 O
unjustifiable 110 123 731 744 O
risk 124 128 745 749 O

Life 0 4 750 754 O
- 4 5 754 755 O
threatening 5 16 755 766 O
bleeding 17 25 767 775 O
episode 26 33 776 783 O
or 34 36 784 786 O
major 37 42 787 792 B-treatment
surgery 43 50 793 800 I-treatment
during 51 57 801 807 O
the 58 61 808 811 O
3 62 63 812 813 B-upper_bound
months 64 70 814 820 I-upper_bound
prior 71 76 821 826 I-upper_bound
to 77 79 827 829 O
substudy 80 88 830 838 O
entry 89 94 839 844 O

Low 0 3 845 848 O
platelet 4 12 849 857 B-clinical_variable
count 13 18 858 863 I-clinical_variable

Male 0 4 864 868 B-gender

Must 0 4 869 873 O
require 5 12 874 881 O
non 13 16 882 885 O
- 16 17 885 886 O
emergency 17 26 886 895 O
surgery 27 34 896 903 B-treatment

Never 0 5 904 909 O
previously 6 16 910 920 O
been 17 21 921 925 O
treated 22 29 926 933 O
with 30 34 934 938 O
FIX 35 38 939 942 B-treatment
clotting 39 47 943 951 I-treatment
factor 48 54 952 958 I-treatment
products 55 63 959 967 I-treatment

No 0 2 968 970 O
confirmed 3 12 971 980 O
history 13 20 981 988 O
of 21 23 989 991 O
FIX 24 27 992 995 B-treatment
inhibitor 28 37 996 1005 I-treatment
formation 38 47 1006 1015 O

Scheduled 0 9 1016 1025 O
to 10 12 1026 1028 O
have 13 17 1029 1033 O
a 18 19 1034 1035 O
major 20 25 1036 1041 B-treatment
non 26 29 1042 1045 I-treatment
- 29 30 1045 1046 I-treatment
emergency 30 39 1046 1055 I-treatment
surgery 40 47 1056 1063 I-treatment
within 48 54 1064 1070 O
approximately 55 68 1071 1084 O
8 69 70 1085 1086 B-upper_bound
weeks 71 76 1087 1092 I-upper_bound
from 77 81 1093 1097 O
the 82 85 1098 1101 O
anticipated 86 97 1102 1113 O
date 98 102 1114 1118 O
of 103 105 1119 1121 O
receiving 106 115 1122 1131 O
the 116 119 1132 1135 O
first 120 125 1136 1141 O
rIX 126 129 1142 1145 B-treatment
- 129 130 1145 1146 I-treatment
FP 130 132 1146 1148 I-treatment
injection 133 142 1149 1158 I-treatment

Subjects 0 8 1159 1167 O
who 9 12 1168 1171 O
have 13 17 1172 1176 O
received 18 26 1177 1185 O
FIX 27 30 1186 1189 B-clinical_variable
products 31 39 1190 1198 O
( 40 41 1199 1200 O
plasma 41 47 1200 1206 O
- 47 48 1206 1207 O
derived 48 55 1207 1214 O
and 56 59 1215 1218 O
/ 60 61 1219 1220 O
or 62 64 1221 1223 O
recombinant 65 76 1224 1235 O
FIX 77 80 1236 1239 O
) 80 81 1239 1240 O
for 82 85 1241 1244 O
> 86 87 1245 1246 O
150 88 91 1247 1250 B-lower_bound
exposure 92 100 1251 1259 I-lower_bound
days 101 105 1260 1264 I-lower_bound
( 106 107 1265 1266 O
EDs 107 110 1266 1269 O
) 110 111 1269 1270 O
, 111 112 1270 1271 O
confirmed 113 122 1272 1281 O
by 123 125 1282 1284 O
their 126 131 1285 1290 O
treating 132 140 1291 1299 O
physician 141 150 1300 1309 O

Subjects 0 8 1310 1318 O
who 9 12 1319 1322 O
have 13 17 1323 1327 O
received 18 26 1328 1336 O
rIX 27 30 1337 1340 B-clinical_variable
- 30 31 1340 1341 I-clinical_variable
FP 31 33 1341 1343 I-clinical_variable
for 34 37 1344 1347 O
≥ 38 39 1348 1349 O
100 40 43 1350 1353 B-lower_bound
EDs 44 47 1354 1357 I-lower_bound
( 48 49 1358 1359 O
single 49 55 1359 1365 O
- 55 56 1365 1366 O
dose 56 60 1366 1370 O
cohorts 61 68 1371 1378 O
) 68 69 1378 1379 O
or 70 72 1380 1382 O
for 73 76 1383 1386 O
≥ 77 78 1387 1388 O
50 79 81 1389 1391 B-lower_bound
EDs 82 85 1392 1395 I-lower_bound
( 86 87 1396 1397 O
repeated 87 95 1397 1405 O
- 95 96 1405 1406 O
dose 96 100 1406 1410 O
cohort 101 107 1411 1417 O
) 107 108 1417 1418 O

Surgery 0 7 1419 1426 B-treatment
substudy 8 16 1427 1435 O

Unwilling 0 9 1436 1445 O
to 10 12 1446 1448 O
participate 13 24 1449 1460 O
in 25 27 1461 1463 O
the 28 31 1464 1467 O
study 32 37 1468 1473 O
for 38 41 1474 1477 O
a 42 43 1478 1479 O
total 44 49 1480 1485 O
of 50 52 1486 1488 O
100 53 56 1489 1492 B-upper_bound
exposure 57 65 1493 1501 I-upper_bound
days 66 70 1502 1506 I-upper_bound

at 0 2 1507 1509 O
least 3 8 1510 1515 O
18 9 11 1516 1518 B-lower_bound
years 12 17 1519 1524 I-lower_bound
of 18 20 1525 1527 O
age 21 24 1528 1531 B-age

chronic 0 7 1532 1539 B-treatment
systemic 8 16 1540 1548 I-treatment
corticosteroid 17 31 1549 1563 I-treatment
treatment 32 41 1564 1573 I-treatment

congenital 0 10 1574 1584 O
FIX 11 14 1585 1588 B-chronic_disease
deficiency 15 25 1589 1599 I-chronic_disease

kidney 0 6 1600 1606 B-chronic_disease
or 7 9 1607 1609 O
liver 10 15 1610 1615 B-chronic_disease
disease 16 23 1616 1623 I-chronic_disease

subjects 0 8 1624 1632 O
requiring 9 18 1633 1642 O
major 19 24 1643 1648 B-treatment
non 25 28 1649 1652 I-treatment
- 28 29 1652 1653 I-treatment
emergency 29 38 1653 1662 I-treatment
surgery 39 46 1663 1670 I-treatment
who 47 50 1671 1674 I-treatment
have 51 55 1675 1679 I-treatment
not 56 59 1680 1683 I-treatment
previously 60 70 1684 1694 I-treatment
completed 71 80 1695 1704 I-treatment
a 81 82 1705 1706 I-treatment
CSL 83 86 1707 1710 I-treatment
- 86 87 1710 1711 I-treatment
sponsored 87 96 1711 1720 I-treatment
rIX 97 100 1721 1724 I-treatment
- 100 101 1724 1725 I-treatment
FP 101 103 1725 1727 I-treatment
lead 104 108 1728 1732 O
- 108 109 1732 1733 O
in 109 111 1733 1735 O
study 112 117 1736 1741 O

subjects 0 8 1742 1750 O
who 9 12 1751 1754 O
have 13 17 1755 1759 O
previously 18 28 1760 1770 O
completed 29 38 1771 1780 O
a 39 40 1781 1782 O
CSL 41 44 1783 1786 B-allergy_name
- 44 45 1786 1787 I-allergy_name
sponsored 45 54 1787 1796 I-allergy_name
rIX 55 58 1797 1800 I-allergy_name
- 58 59 1800 1801 I-allergy_name
FP 59 61 1801 1803 I-allergy_name
study 62 67 1804 1809 O

surgical 0 8 1810 1818 B-treatment
substudy 9 17 1819 1827 I-treatment
does 18 22 1828 1832 O
not 23 26 1833 1836 O
have 27 31 1837 1841 O
any 32 35 1842 1845 O
additional 36 46 1846 1856 O
exclusion 47 56 1857 1866 O
criteria 57 65 1867 1875 O
, 65 66 1875 1876 O
although 67 75 1877 1885 O
subject(s 76 85 1886 1895 O
) 85 86 1895 1896 O
in 87 89 1897 1899 O
France 90 96 1900 1906 O
will 97 101 1907 1911 O
not 102 105 1912 1915 O
be 106 108 1916 1918 O
eligible 109 117 1919 1927 O
for 118 121 1928 1931 O
the 122 125 1932 1935 O
surgery 126 133 1936 1943 B-treatment
sub 134 137 1944 1947 I-treatment
- 137 138 1947 1948 I-treatment
study 138 143 1948 1953 I-treatment

up 0 2 1954 1956 O
to 3 5 1957 1959 O
18 6 8 1960 1962 B-upper_bound
years 9 14 1963 1968 I-upper_bound
of 15 17 1969 1971 O
age 18 21 1972 1975 B-age

vitamin 0 7 1976 1983 B-chronic_disease
K 8 9 1984 1985 I-chronic_disease
deficiency 10 20 1986 1996 I-chronic_disease
of 21 23 1997 1999 O
the 24 27 2000 2003 O
newborn 28 35 2004 2011 O

